IHC ERPR Test
Introduction to the IHC ERPR Test
The IHC ERPR test, or Immunohistochemistry Estrogen and Progesterone Receptor test, is a pivotal diagnostic tool used primarily in oncology. It evaluates the presence of estrogen and progesterone receptors in tumor tissues, which is crucial for determining the most effective treatment options for patients diagnosed with breast cancer. Understanding the receptor status can guide oncologists in tailoring therapies that are more likely to succeed, thereby improving patient outcomes.
What the Test Measures
This test specifically measures the expression of estrogen and progesterone receptors in cancerous tissues. High levels of these receptors often indicate that hormone therapy may be beneficial for the patient, while low or absent receptor levels may suggest alternative treatment pathways.
Who Should Consider This Test
The IHC ERPR test is recommended for:
- Patients diagnosed with breast cancer.
- Individuals with a family history of breast cancer.
- Patients exhibiting symptoms such as unexplained breast lumps or changes.
- Those with risk factors including age, genetic predisposition, or previous breast conditions.
It is essential for patients to consult their healthcare provider to determine if this test is appropriate for their specific situation.
Benefits of Taking the Test
Undergoing the IHC ERPR test offers numerous benefits:
- Helps in determining the most effective treatment options.
- Guides decisions on hormone therapy, improving treatment efficacy.
- Enables personalized care tailored to the individual’s cancer profile.
- Provides critical information that can influence prognosis and treatment planning.
Understanding Your Results
Results from the IHC ERPR test are typically available within three days. The outcomes will indicate the presence or absence of estrogen and progesterone receptors. A positive result may suggest hormone therapy as a viable treatment option, while a negative result may lead to alternative therapies. It is crucial to discuss your results with your healthcare provider for a comprehensive understanding and to make informed decisions about your treatment plan.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| IHC ERPR | 80,000 | 120,000 |
Booking the Test
To ensure accurate results, the IHC ERPR test can only be conducted with a doctor’s prescription. Please note that a prescription is not applicable for surgery and pregnancy cases or for individuals planning to travel abroad.
For more information or to schedule your IHC ERPR test, please call or WhatsApp us at +2348110567037. Take charge of your health today!
